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I. INTRODUCTION 
The American Thoracic Society (ATS) state-
ment on the Standardization of Spirometry 
was published 8 years ago and was based on 
the Snowbird Workshop held in 1977 (1). Since 
that time, we have had years of practical ex-
perience with these recommendations, which 
have been widely endorsed (2-5). In addition, 
the "state of the art" of spirometry has ad-
vanced as a result of scientific studies that 
have provided additional data relating to per-
formance of spirometry. Simultaneously, the 
use of computers for spirometry measurement 
has become commonplace. As a consequence, 
the American Thoracic Society's Board of 
Directors asked that the Committee on Profi-
ciency Standards for Clinical Pulmonary 
Function Laboratories review and update the 
initial statement. 
The ATS statement on standardization of 
spirometry has had a far-reaching effect on 
manufacturers and users of spirometers. In 
some cases, manufacturers have used the 
document as a "minimum" performance re-
--~----------------------------~~ 
quirements document. We are concerned with 
this approach and encourage manufacturers 
to continue to seek excellence in design so that 
the "state of the art" for spirometers will ex-
ceed the ATS recommendations. Some re-
search protocols will necessitate even more 
stringent requirements than stated here_ 
We frequently hear the appeal that an in-
expensive and, although not explicitly stated, 
"less accurate" spirometer is all that is needed 
in clinical practice. We feel this premise is 
flawed since treatment decisions need to be 
based on the best data available, whether data 
arises from a hospital-based diagnostic labo-
ratory or a physician's office. During recent 
testing of commercially available spirometers, 
devices were found that had FVC errors as 
large as 1.5 L, a 2507o error (6). If a bronchodi-
lator treatment is made based on spirometric 
data, subsequent spirometric measurements 
are often made to determine if the treatment 
was effective. If an inaccurate spirometer is 
used, especially a spirometer with poor repeat-
ability, the improvement or degradation meas-
ured may be entirely spirometer-related and 
have nothing to do with the subject's response 
to treatment. 
Spirometry is used to affect decisions about 
individual patients such as: Does this subject 
have enough evidence of impaired lung func-
tion to preclude working at a specific job? 
Should steroid treatment be continued? Does 
this person qualify for full disability compen-
sation on the basis of impaired lung func-
tion? Should the subject's insurance status be 
changed? Answers to each of these questions 
based on spirometric maneuvers can have a 
dramatic effect on a person's lifestyle, stan-
dard of living, and future treatment (5). 
Similarly, accurate spirometers are required 
for epidemiologic studies. Rates of improve-
ment or deterioration of pulmonary function 
measured in relation to environmental ex-
posures and/or personal characteristics may 
be erroneous if inaccurate spirometers are 
used or less sensitive if imprecise spirometers 
are used (7). 
Reprints may be requested from your state or 




























Fig. 1. Spirometry standardization steps. 
Testing of commercially available spirom-
eters, with a computer-driven mechanical sy-
ringe, has recently been completed. It was 
found that already 27 of 53 (510Jo) spirome-
ters met the new and rigorous ATS recom-
mendations outlined in this article. With the 
aid of microcomputers, several flowmeter type 
spirometers now meet the ATS requirements 
(6). Not surprisingly, computer software was 
one of the major reasons for device failure. 
Maximizing the clinical usefulness of 
spirometry depends upon a number of fac-
tors, ranging from equipment selection to in-
terpretation, and ultimately involves clinical 
assessment. Figure I is a flow diagram of these 
steps. The first step is choosing the equipment. 
The Snowbird Workshop (I) and now this up-
date give recommendations for equipment 
used for spirometry. Spirometer users should 
carefully select equipment that meets the ATS 
recommendations to assure that spirometry 
testing can be done accurately. The second 
step in the process involves validating that the 
spirometer design and that a production de-
vice meet the recommendations. Detailed 
methods for performing the validation test-
ing are outlined later in this article. Because 
almost no physicians and few clinical pulmo-
nary function laboratories have the capabil-
ity to exhaustively test and validate spirome-
ters, an independent testing laboratory has 
been set up at LDS Hospital in Salt Lake City, 
Utah. Other independent laboratories are en-
couraged to enter the spirometer validation 
field. 
The ATS promulgates standards but does 
not act as a certifying agency to verify com-
pliance with these standards. Before a user 
purchases a spirometer, he or she would be 
wise to (1) ask the manufacturer to provide 
summary data that demonstrates that the de-
vice being considered meets the ATS recom-
mendations, and (2) review results of spirom-
etry testing from independent testing labora-
tories. 
Even after the equipment has been found 
to meet ATS recommendations and has been 
validated, spirometers (like other pieces of me-
chanical, electrical, or computer equipment) 
must be routinely checked for performance 
quality. Recommendations for spirometer 
quality control have been developed by the 
ATS and are summarized in this article. 
Spirometry is an effort-dependent maneu-
ver that requires careful patient/ subject in-
struction, understanding, coordination, and 
cooperation. Thus, performance recommen-
dations are important components of testing. 
Part of the recommendation is to obtain a 
sufficient number of maneuvers that are of 
adequate quality and then determine if these 
acceptable maneuvers are reproducible. Once 
spirometry maneuvers have been performed, 
they need to be either measured by hand or 
by use of computer techniques. Measurement 
procedures are included in this article to help 
assure that uniform methods are used and that 
comparable results are obtained. These recom-
mendations include considerations such as 
using "back extrapolation" for determining 
the "start of test" time zero point for deter-
mination of measures such as FEY, . 
Interaction between technician and patient 
or subject is crucial to performing adequate 
spirometry since it is such an effort-dependent 
maneuver. Technicians must be selected and 
trained and maintain a high level of profi-
ciency to assure optimal results. 
The effort-dependent spirogram must be 
carefully scrutinized for quality. Recommen-
dations about quality, acceptability, and 
reproducibility of test result are presented. Af-
ter adequate results are obtained, they are usu-
ally compared with reference values to make 
an assessment (interpretation) of the results. 
Future ATS efforts should be directed at in-
vestigating and providing guidelines for select-
ing reference values and interpretive methods. 
This article provides only background ma-
terials for these future developments. 
Clinical assessment is a crucial part of the 
patient / subject-physician/ investigator inter-
action and should be an integral part of the 
entire process. Results obtained from spirom-
etry are only one part of the much more com-
plex patient care relationship of research data 
analysis. 
Definitions 
Standard definitions are important to assure 
that everyone understands each test and its 
performance methodology. All terms and ab-
breviations used here are based on a report 
of the American College of Chest Physicians 
AMERICAN THORACIC SOCIETY 
(ACCP)-ATS Joint Committee on Pulmonary 
Nomenclature (8). 
II. EQUIPMENT RECOMMENDATIONS 
Equipment selection is pivotal to acquiring 
accurate test results. Spirometer equipment 
recommendations apply to all diagnostic 
spirometers whether used for clinical, diag-
nostic, or epidemiologic purposes. Instrumen-
tation recommendations should be followed 
to provide accurate spirometric data and in-
formation that is comparable from labora-
tory to laboratory and from one time period 
to another(!). The accuracy of a spirometer 
system depends on the resolution (i.e., the min-
imal detectable volume or flow) and linearity 
of the entire system- from volume or flow 
transducer to recorder, display, or processor. 
Errors at any step in the process affect the 
accuracy of the results obtained (see Appen-
dix A). For example, if a sample point is not 
available at exactly 1.0 s after the back ex-
trapolated "time zero," then linear interpola-
tion of the volume curve should be used to 
find FEY, . 
The equipment recommendations for spi-
rometry are summarized in table I. 
Recommendation-Vital Capacity (VC) 
YC = The maximal volume of air exhaled 
from the point of maximal inhalation. This 
is also considered the "slow" vital capacity. 
Expressed in liters (BTPS) . BTPS = Body con-
ditions: normal body temperature (37 ° C), 
ambient pressure, saturated with water vapor. 
Recommendation- VC Equipment 
If a spirometer purports to measure VC, it 
should continue to accumulate volume for AT 
LEAST 30 s. Spirometers should be capable 
of measuring volumes of AT LEAST 7 l 
(BTPS) with flows between zero and 12 Lis. 
Accuracy required is AT LEAST ± 30Jo of 
reading or ± 0.050 L, whichever is greater. 
Rationale. Based on Hankinson and Peter-
sen's data on 9,347 working coal miners, the 
range for volume and flow were established 
(1, 9). Of these miners, 99.250Jo had a forced 
vital capacity of less than 7.25 l (1). If the 
spirometer is used for both inspiration and 
expiration, a volume capacity of greater than 
7 L may be necessary. The volume require-
ment of 7 L also applies to children (I, 3, 10, 
II). Older men and women have volumes simi-
lar to those of adolescents (10-12). A 7-l 
spirometer will not measure the person with 
"super" lungs, but it will cover the majorit y 
ofthepopulation. Accuracy of± 30Jo ofread-
ing or ± 0.050 L, whichever is greater, is based 
on the data of Hankinson and Petersen (1 , 
9). Their data showed coefficient of varia-
tion on the same subject on different days 
of 30Jo or less (1). These data have been sub-
stantiated (13-15). A spirometer must be capa-
ble of measuring flows in the range of zero 
to 12 L/ s. The 12 L/ s maximal flow rate se-
lection was determined from Hankinson and 
Petersen's data (I, 9) that showed that less than 
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7 L ± 3% of reading or ± 0.050 L, whichever is greater 
7 L ± 3% of reading or ± 0.050 L, whichever is greater 
7 L ± 3% of reading or ± 0.050 L, whichever is greater 
zero to 12 
zero to 12 
zero to 12 
30 
15 
Time Zero The time point from which all FEV, measurements are taken . 
FEF, •. , • .., 7.0 L ± 5•tb of reading or ± 0.200 Us, whichever is greater zero to 12 
zero to 12 




± 12 Us ± 5% of reading or ± 0.200 Us, whichever is greater 
Sine wave 250 Umin at TV of 2 L within ± 5% of reading 
15 
12 to 15 
about 711fo of the miners had flow rates greater 
than 12 Lis. 
Recommendation- Forced Vital 
Capacity (FVC) 
FVC = Maximal volume of air exhaled with 
maximally forced effort from a posi tion of 
maximal inspiration. Vital capacity per-
formed with a maximally forced expiratory 
effort. Expressed in liters (BTPS) . 
Recommendation- FVC Equipment 
The spirometer should be capable of meas-
uring volumes up to AT LEAST 7 L (BTPS) 
with an accuracy of AT LEAST ± 3% of 
reading or ± 0.050 L, whichever is greater, 
with flows between zero and 12 L/s. The 
spirometer should be capable of accumulat-
ing volume for AT LEAST 15 s, although 
longer times are recommended . 
Rationale. Subjects and patients can exhale 
for longer than 15 s, so instruments should 
be capable of measuring their true FVC. For 
the FVC maneuver, the volume requirements 
are the same as for the VC (1, 9-13). The 
spirometer must be capable of measuring 
flows in the range of zero to 12 L/ s. The 12 
L/s maximal flow rate selection was based 
on the Hankinson and Petersen data that 
showed that fewer than 7% of their coal 
miners had peak flows greater than 12 L/ s 
(I, 9). 
Recommendation-Timed Forced 
Expiratory Volume (FEVt) 
FEY, = The volume of air exhaled in the 
specified time during the performance of the 
FVC, e.g., FEY 1 for the volume of air exhaled 
during the first seconds of FVC. Expressed 
in liters (BTPS) . 
Recommendation-FEV1 Equipment 
Measuring the FEY 1 requires a spirometer 
having a volume of AT LEAST 7 L. The 
spirometer should measure the FEY, within 
an accuracy of AT LEAST± 3% of reading 
or ± 0.050 L, whichever is greater with flows 
between zero and 12 L/s. The "start of test" 
for purposes of timing WILL BE determined 
± 5% ± 3% 
by the back extrapolation method (1, 16, 17) 
or a method shown to be equivalent (see fig-
ure 2). For hand measurements, the back ex-
trapolation method traces back from the 
steepest slope on the volume-time curve (see 
figure 2) (17 , 18). For purposes of computer 
methods of back extrapolation, we recom-
mend using the largest average slope over a 
70-ms period (19) (see Appendix A). The re-
sistance to airflow from zero to 12.0 L/ s 
should be less than 1.5 em H 20 per L/ s. 
Rationale. FEY, measurement is in-
fluenced by the point selected as the start of 
the maneuver. A uniform method of select-
ing the point is required to maintain con-
sistency. The back extrapolation (1, 16, 17) 
method is the most consistent and accepted 
method (see Section VI for measurement 
procedures) and should be used until other 
methods are demonstrated to give equivalent 
results. One attempt to demonstrate equiva-
lency of volume or flow threshold methods 
for detection of start of test by back extrapo-
lation was unsuccessful (20). ·Resistance to 
flow affects the FEY 1 and other timed expi-
rations (21-26). 
Recommendation- FEF25- 75r.. 
FEF,._,,.., = Mean forced expiratory flow 
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Fig. 2. Typical subject waveform of a volume-time spiro-
gram illustrating back extrapolation to determine "time 
zero." Extrapolated volume • Vext · 
Resistance and 
Back Pressure 
Less than 1 .5 
em H20/Us, from 
zero to 12 Us 
Determined by back 
extrapolation. 
Same as FEV1 
Same as FEV, 
Pressure less than 
± 10 em H20 
at 2-L TV 
at 2.0 Hz 
Test Signal 
3-L Cal Syringe 
24 standard waveforms 
24 standard waveforms 
24 standard waveforms 
Manufacturer proof 
Sine wave pump 
zero to 4 Hz ± 10% 
at ± 12 Us 
called the maximal midexpiratory flow rate 
(MMEF). Expressed in liters/ sec (BTPS). 
Recommendation- FEF,._,, ., Equipment 
The FEF,._,.., should be measured with an 
accuracy of AT LEAST ± 5% of reading 
or ± 0.200 L/ s, whichever is greater. The 
FEF 25-1•·· should be measured on a system 
that meets the FVC re::ommendations. 
Rationale. The FEF,._,.., maneuver has a 
much larger intrasubject variability than FVC 
or FEY, (27). Additionally, 2 measurements 
of both volume and time are required; there-
. fore, the relaxed accuracy requirement is justi-
fied. Manufacturers and software developers 
should be aware that a major error in 
FEF,._,.., can occur when slow sampling 
rate analog to digital converters are used. With 
these systems, it may be necessary to "inter-
polate" between sample points to get the ex-
act 25% and 75% of FVC points. 
Recommendation- Flow (V) 
V = Instantaneous forced expiratory flow. 
Expressed in liters/ sec (BTPS) . 
Recommendation- Flow Measurement 
Flow may be measured electronically or 
manually. Where flow-volume loops or other 
uses of flow are made, with flow in the range 
of - 12 to 12 Lis, the flow should be within 
± 5% of reading or ± 0.200 L/ s, whichever 
is greater. 
Rationale. Flow-measuring devices such as 
pneumotachometers are increasingly being 
used to measure spirometric parameters (6). 
With flow devices, volume is determined bv 
integration of flow. Flow calibration method-s 
with sufficient accuracy have not yet been de-
veloped. Volume spirometers differentiate vol-
ume signals to determine flow. With the 
"noise," phase shift, and associated problems, 
flows accurate to within ± 5% are thought 
to be adequate. Whenever a flow signal is in-
tegrated to measure volume, the volume ac-
curacy requirements are ± 3% of reading or 
± 0.050 L, whichever is greater (1). Instan-
taneous flow parameters such as FEF,."io, 
FEFmax, and Peak Expiratory Flow Rate 
(PEFR) are very device-dependent, and as " 
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consequence their measurements are quite 
variable (6). 
Recommendation- Forced Expiratory 
Time (FET) 
FET = Time from the back extrapolated 
"time zero" until the first inspiratory effort 
following FVC, or the end of expiratory effort. 
Rationale. The FET helps show that the 
duration of FVC effort was acceptable, an es-
pecially useful measure when using flow/ vol-
ume loops. 
Recommendation- Maximal Voluntary 
Ventilation (MVV) 
MVV = The volume of air exhaled in a speci-
fied period during repetitive maximal respi-
ratory effort. Expressed in liters/ min (BTPS). 
Recommendation- MVV Equipment 
When a spirometer is used for measuring 
MVV, it should have an amplitude-frequency 
response that is flat within ± IOOJo from zero 
(DC) to 4 Hz at flow rates of up to 12 L/ s 
over the volume range. The time for exhaled 
volume integration or recording should be no 
less than 12 or more than 15 s (21). The indi-
cated time should be accurate to within ± 3%. 
Rationale. For the MVV maneuver, the fre-
quency content of the volume-time signal is 
high (28, 29). Results are dependent on the 
patient effort as well as the frequency response 
characteristics of the spirometer (21 , 30-32). 
General Background- Spirometry 
Recorders/Displays 
Paper records or graphic displays of spirom-
etry signals are REQUIRED and are used for 
3 primary purposes: 
(/)DIAGNOSTIC function-when wave-
forms are to be used for quality control or 
review of the forced expiratory maneuver to 
determine if the maneuver was performed 
properly, so that unacceptable maneuvers can 
be eliminated. 
(2) VALIDATION function- when wave-
forms are to be used to validate the spirome-
ter system hardware and software for accuracy 
and reliability through the use of hand meas-
urements (for example, measurement of FEY, 
using back extrapolation by comparing com-
puter- and hand-determined FEY,). 
(3) HAND MEASUREMENTfunction-
when waveforms are to be hand measured for 
spirometric parameters (FVC, FEY, etc.) in 
the absence or failure of a computer. 
With recent advances in computer technol-
ogy, there are many different ways to display 
and record spirometric waveforms. The Com-
mittee has chosen to broaden the initial scope 
of the spirometry standardization article to 
further encourage use of computer tech-
nology. 
A Jess stringent paper recorder requirement 
will suffice for DIAGNOSTIC purposes com-
pared to VALIDATION and HAND MEAS-
UREMENT needs. If no paper recorder or 
printer is available or if the paper recorder 
does not meet the requirements for VALIDA-
AMERICAN THORACIC SOCIETY 
TABLE 2 
MINIMUM REQUIRED SCALE FACTORS FOR TIME. VOLUME. AND 
FLOW GRAPHICS 
Diagnostic Validation and Measurement 
Resolution Scale Resolution 
Required Factor Required Scale Factor 
Volume (L) 0.050 
(mm/L) 
Flow (Us) 0 .20 
(mm/Us) 
Time (msec) 20 
(cm/s) 
TION and HAND MEASUREMENT appli-
cations, then proof of validation of the ac-
curacy and stability of the spirometer by an 
independent laboratory MUST be provided 
by the manufacturer. For these computer 
methods, any new software releases MUST 
also be validated. Users and manufacturers 
should realize that for certain applications (for 
example, for disability determination and le-
gal cases), diagnostic size displays are NOT 
adequate (21). For example, with the Cotton 
Dust standard " ... tracings must be stored 
and available for recall and must be of suffi-
cient size that hand measurements may be 
made . .. " (33). Also users will customarily 
not be able to verify accuracy and stability 
of spirometers by themselves in the absence 
of an adequate paper recording. 
Recommendation- FVC Volume-
Time Curves 
When a volume-time curve is plotted or dis-
played, the volume scale for each of the fol -
lowing conditions should be AT LEAST: 
(/)DIAGNOSTIC function: 5 mm/ L (BTPS) 
for volume so the graphs will be large enough 
to allow recognition of unacceptable maneu-
vers and disease patterns. 
(2) VALIDATION and HAND MEAS-
UREMENT functions: 10 mm / L (BTPS) for 
volume for validation and measurement func-
tions. See section below for time scale of 
volume-time plots. 
Recommendation- FVC Maneuver 
Time Scale 
(I) DIAGNOSTIC function: time scale, AT 
LEAST I cm/ s. 
(2) VALIDATION and HAND MEAS-
UREMENTfunctions: time scale, AT LEAST 
2 cm/ s; larger time scales are preferred (at least 
3 cm/ s) when hand measurements are made, 
but are not required (1, 34, 35). 
Rationale. A recent study (35) evaluating 
the effects of time scale (paper speed) on 
spirometry accuracy has recommended a time 
scale of at least 3 cm/ s if spirograms are to 
be accurately measured by hand. The adop-
tion of this more stringent criterion was con-
sidered, but not adopted as a minimum 
recommendation. The new study further sup-
ports the current 2 cm/ s requirement as a 









many spirometers now make use of com-
puters, time resolution and sampling rate be-
come important design issues. The tutorial 
in Appendix A and table 2 give further specifi-
cation details. 
Recommendation- Flow-Volume Curves 
When a flow-volume curve is plotted or dis-
played, exhaled flow should be plotte.d up-
wards, and exhaled volume towards the right. 
A 2:1 ratio should be maintained between the 
flow and volume scales, e.g. , 2 L/ s of flow 
and I L of exhaled volume should be the same 
distance on their respective axes. The mini-
mum flow and volume scales should be AT 
LEAST as shown in table 2. 
Rationale. Currently, flow-volume curves 
are displayed with a variety of orientations 
and aspect ratios, hindering the usefulness of 
visual pattern recognition. Also, some cur-
rent digitally generated curves do not have 
sufficient flow or volume resolution . Manu-
facturers and users should be aware of these 
limitations. 
Ill. EQUIPMENT VALIDATION 
Recommendation- FVC Validation 
of Test Equipment 
The diversity ofFVC maneuvers encountered 
in clinical practice are currently best simu-
lated by the use of the 24 standard waveforms 
developed by Hankinson and Gardner (19, 
36). These waveforms can be used to drive 
a computer-controlled mechanical syringe for 
testing actual hardware and software, (6, 37) 
or they can be put into a system in digital form 
to evaluate ONLY the software. Appendix C 
shows a volume-time and a flow-volume plot 
of each of the 24 standard waveforms and 
includes table 4, which gives the measured 
values. The American Thoracic Society also 
provides these waveforms on floppy disks for 
an IBM PC. Appropriate corrections for using 
gas at ambient temperature, ambient humid-
ity instead of BTPS may need to be made for 
some mechanical syringe-spirometer combi-
nations. 
The validation limits for volume are: Vol-
ume (FVC, FEY,) ± 3.5% of reading or ± 
0.070 L, whichever is greater; and Flow 
(FEF2,.,.~.) ± 5.507o of reading or ± 0.250 
L/ s, whichever is greater. The error range was 
expanded from the ATS spirometry recom-
~---------~-----~ 
----
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mendation stated earlier to allow for errors 
associated with mechanical syringes (6). Me-
chanical syringes used for validation must be 
accurate within ± 0.025 L for FVC and FEV, 
and ± 0.100 L/s for FEF,,_,..,. 
Rationale. Since the publication of the ATS 
spirometry statement, additional efforts by 
the Association for the Advancement of Med-
ical Instrumentation (AAMI) (36) have re-
sulted in the development of 24 standard 
waveforms for spirometer evaluation (19). Be-
cause these waveforms were obtained from 
recordings of actual subject waveforms and 
have been accepted by AAMI, and because 
better standard signals are not available, the 
ATS recommends their use as a test signal for 
FVC for evaluation of software or entire 
spirometry systems. When evaluating spirom-
eters in which the 24 standard waveform sets 
are injected from a computer-controlled me-
chanical syringe (6, 37), the spirometer will 
qualify as meeting ATS requirements if fewer 
than 1 in every 20 measured values is outside 
the limits, provided the failure does not rep-
resent an inherent design defect. 
Flows cannot be easily generated without 
noise; therefore, the frequency of the noise 
should be stated. In addition, a step function 
signal should be generated with the mechani-
cal syringe, and the resulting signal should 
be sampled at a frequency of at least 1,000 
Hz to determine the dynamic characteristics 
of the driving syringe. Typically, these sys-
tems have second-order oscillatory character-
istics. By using the step function signal, the 
natural frequency and damping coefficients 
can be determined . Some spirometer 
manufacturers have appropriately purchased 
a computer-based syringe system for dynamic 
testing of each of their own spirometers (MH 
Custom Design and Manufacturing, 70 Fern 
Drive, Midvale, UT 84047); however, spirom-
etry system designs and a production model 
must be validated by an independent testing 
laboratory. 
Recommendation- MVV Validation 
Equipment 
When tested with a pump producing a sinu-
soidal waveform, the indicated response of 
the spirometer in incrementally increased 
flows up to 250 Llmin signal, produced with 
stroke volumes up to 2 L, should be accurate 
within ± 50?o of reading. During the testing, 
the pressure at the mouthpiece should not ex-
ceed ± 10 em H 20. For volume spirometers, 
these requirements apply throughout their vol-
ume range. 
IV. EQUIPMENT QUALITY CONTROL 
Routine equipment preventive maintenance, 
cleaning, calibration checks, verification, and 
quality control are important to assure ac-
curate spirometry results (38). A spirometry 
procedure manual is an important base for 
a quality assurance program. The manual 
should contain a quality control plan, guide-
lines for ordering spirometry, guidelines for 
performing spirometry, and guidelines for 
reporting spirometry results. See the docu-
ment "ATS Quality Assurance for Pulmonary 
Laboratories" for more details (38). 
The role of spirometric equipment in the 
transmission of infections has not been es-
tablished (39). However, general suggestions 
based on a reasonable theoretical rationale 
or data from other sources are appropriate. 
A recent publication by the Centers for Dis-
ease Control outlines 9 recommendations: (I) 
handwashing indications, (2) handwashing 
technique, (3) handwashing products, (4) 
handwashing facilities, (5) fluids and medi-
cations, (6) handling blood specimens, (7) 
maintenance of equipment, (8) protection of 
patients from other infected/ colonized pa-
tients or staff, and (9) microbiologic monitor-
ing (39) . 
Recommendation- Equipment Quality 
Control 
The spirometer's ability to accurately meas-
ure volume should be checked AT LEAST 
daily with a calibrated syringe with a volume 
of at least 3 L. During industrial surveys or 
other field studies in which a large number 
of subject maneuvers are done, the equipment 
should be calibrated prior to testing daily if 
in regular use and then every 4 h during use 
(38). Although there is minimal day-to-day 
variation in volume calibration, daily calibra-
tion checking is highly recommended so that 
the onset of a problem can be determined 
within 1 day, eliminating needless reporting 
of false values for several weeks or months 
and also to help define day-to-day laboratory 
variability. For survey testing in which a large 
number of maneuvers are done, the 4-h period 
of calibration checking is recommended to 
prevent invalidation of data from a large num-
ber of maneuvers. Spirometer systems should 
be evaluated for leaks on a daily basis (17, 
40). The Intermountain Thoracic Society 
Manual suggests that leaks can be detected 
by applying a constant positive pressure of 
3 em H,O or more with the volume spirome-
ter outlet occluded. Any observed volume 
change after 1 min is indicative of a leak (17) . 
AT LEAST quarterly, volume spirometers 
should have their calibration checked over 
their entire volume range (in 1-L increments) 
using a calibrated 3-L syringe (6). Two emp-
tying times for the 3-L syringe are indicated: 
0.5 to I s (flow in the range of 3 to 6 Lis) 
and at least 6 s (flows less than 0.5 Lis). As-
sessing the recorder time scale accuracy with 
a stopwatch should be performed AT LEAST 
quarterly. An accuracy of within 10?o should 
be achieved. If equipment is changed or relo-
cated (e.g., industrial surveys), calibration 
checking and quality control procedures 
should be repeated prior to initiating further 
testing. 
V. MANEUVER PERFORMANCE 
RECOMMENDATIONS 
Personnel Qualifications 
The ATS has made recommendations for lab-
oratory personnel performing a variety of pui-
monary function testing tasks (41). In ad d 
tion to recommending at least a high scho 
training background, strong mathemat: 
training was encouraged. Also I or more ye0 
of college or equivalent training are preferr· 
for technicians performing spirometry. F· 
pulmonary function laboratories, 6 mom : 
of supervised training time is recommen d . 
for performing spirometry. If troublesh o: 
ing is to be a part of the laboratory techr 
cian's responsibility, a training period of I yt . 
is recommended. The ATS has taken a stro: 
position that the Medical Directors must he 
appropriate training and be responsible ; 
all pulmonary function testing (42) . Trai ni 
for doing epidemiologic spirometric tes 1 i · 
may be more intensive than that of a tec h; 
cian for a general pulmonary laboratory tt 
ing and may thus be accomplished m< 
quickly. For industrial/occupational testiL 
there are training requirements mandated 
the National Institute for Occupational Sa f. 
and Health (NIOSH) and industry and 1 
ACCP (18, 33, 43). 
Several excellent training manuals h. 
been prepared for performance of spiro r: 
try (17, 18, 33, 44), and NIOSH approves 1r2 
ing courses (18). 
Rationale. The testing of equipment c.· 
wide-scale proficiency testing of pulmon:, 
function equipment is not currently feasi r 
However, using laboratory personnel 
"known subjects" and performing im • 
laboratory and inter-laboratory testing , . 
be helpful (38). In addition, the ATS ha-. : 
cently published guidelines for "Quality /-
surance in Pulmonary Function Labor2: 
ries," (38) which are recommended. 
With the decrease in size and cost of mi ,·: 
processors and the increase in their speed a : 
reliability, most spirometer systems will c,, . 
tain some type of digital computer. Ind ec 
in a recent test of 53 commercially avail a t 
spirometers, only 3 did not contain a co; 
puter (6). New quality assurance problems\' 
occur as pulmonary function laboratorie> r . 
come more reliant on digital computers a: 
associated automation (45, 46). 
The use of computers to perform spirorr. 
try has accelerated in the past 5 years an d 1 i 
trend may be advantageous to obtain accu r,, 
spirometry (5, 35). The recent testing of co r: 
mercially available spirometers showed t h. 
a major source of errors was in computer so ! 
ware (6). Because of the increased use of cor: 
puters in pulmonary laboratories and i • 
problems associated with them (6, 45) , t: · 
ATS has published "Computer Guidelines f . 
Pulmonary Laboratories" (46), which shou · 
be followed. 
Recommendation- FVC Subject 
Instruction and Maneuver 
Subjects will be instructed in the FVC nL 
neuver, and the appropriate technique will t· 
demonstrated. A MINIMUM of 3 accept a b . 
FVC maneuvers will be performed. If a sul 
ject has large variability between expirato1 
maneuvers, reproducibility criteria may rc 




LARGEST FVC o!< 
"BEST TESr ' CURVE 
Fig. 3. Flow-chart diagram of FVC spirometry testing. 
performed. See figure 3 and Section VII for 
further clarification. 
Recommendation- FVC End of 
Test Criteria 
Subjects should be verbally exhorted to con-
tinue to squeeze out the air at the end of the 
maneuver. "End of Test" will occur when there 
is: 
(!) an obvious plateau in the volume-time 
curve resulting in no change in volume for 
AT LEAST 2 s (a volume decrease is, for the 
purposes of end of test selection, equivalent 
to no change in volume) with an exhalation 
time of AT LEAST 6 s (longer times are fre-
quently needed for subjects with airway ob-
struction). For the purposes of this criterion, 
no change in volume is the minimal detect-
able volume of the spirometer. Minimum de-
tectable volume MUST BE AT LEAST 0.040 
L ; OR 
(2) a forced exhalation of reasonable dura-
tion. (For example, exhalation times of greater 
than 15 s in subjects with severe airway ob-
struction will rarely change clinical decisions 
and longer exhalations are seldom justified; 
manufacturers should note, however, that sev-
eral of the 24 test waveforms have durations 
longer than 20 s); OR 
(3) when, for legitimate clinical reasons, the 
subject cannot or should not continue fur-
ther exhalation. 
Although the end of test criteria defined 
above are reasonable and will perform ade-
quately in most situations, spirometers should 
not prevent the continued accumulation of 
volume after the end of test criteria are met . 
We encourage spirometer designs that allow 
technicians to encourage subjects to breathe 
out for as long as they can or until there is 
an inspiration. 
Rationale. A recent study (19) using stan-
dard waveforms has shown that application 
of the earlier ATS-recommended "end of test" 
criteria (1) prematurely terminates the FVC 
maneuver, resulting in as much as a 90Jo reduc-
tion in the measured FVC. Because the origi-
nal recommendation was not based on data 
from subjects that covered the full spectrum 
of the population, the "end of test" criteria 
are now being updated . 
Requiring that there be no change in vol-
ume for at least 2 sis probably similar to long-
standing manual methods. We were reluctant 
to use the minimum volume accuracy of 0.050 L 
for the minimum detectable volume because 
most spirometers can resolve volume less than 
0.050 L. Manual spirometers with a strip chart 
recorder can typically resolve 0.025 L, and 
a spirometer with a digital shaft encoder can 
typically resolve a 0.010-L volume (47). The 
second "end of test" criterion (reasonable du-
ration of 15 s) is necessary to avoid prolonged 
expirations in subjects with severe airway ob-
struction in which more prolonged expiratory 
efforts will not change the clinical decision. 
Recommendation- Minimum 
FVC Exhalation Time 
A minimum exhalation time of 6 s, unless 
there is an obvious plateau, is required to ob-
tain maximal FVC results. Longer times are 
often required to achieve "end of test," par-
ticularly in obstructed individuals. 
Recommendation- FVC Satisfactory 
Start of Test Criteria 
To achieve accurate "time zero" and ensure 
that the FEY 1 comes from a maximal effort 
curve, the extrapolated volume should be less 
than 50Jo of the FVC or 0.100 L, whichever 
is greater. See figure 2 for example of back 
extrapolation. 
Rationale. The allowable extrapolated vol-
ume of the current ATS recommendations was 
10% of the FVC or 0.100 L, whichever was 
greater, which can result in very slow starts 
with low peak flows being acceptable (1 , 
48-50). In addition, FEY 1 from submaximal 
efforts can be larger than those obtained when 
a maximal effort is performed, both due to 
a volume of air being exhaled without being 
timed (the extrapolated volume) and to less 
dynamic compression of airways in some sub-
jects with submaximal efforts. Because the 
largest FEY 1 is reported, a falsely elevated 
FEY 1 may be used in the final report. The 
lower allowable extrapolated volume should 
reduce the effect of submaximal effect on the 
reported FEY I · 
Recommendation- FVC: Maximum 
Number of Maneuvers 
Although there may be some circumstances 
in which more than 8 consecutive FVC maneu-
vers are needed, 8 maneuvers is considered 
a practical upper limit for most subjects. 
Rationale. After several forced expiratory 
maneuvers, fatigue begins to take its toll on 
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subjects and, thus, on their spirometric pa-
rameters. In addition, some subjects may ex-
hibit spirometry-induced bronchospasm, and 
additional maneuvers would be of little added 
value. Therefore, an upper limit of the num-
ber of maneuvers is warranted. Ferris and as-
sociates (51) and Kanner and colleagues (15) 
have reported that for adults and children, 
8 maneuvers is a practical upper limit. 
Recommendation- FVC Environmental 
Conditions 
Spirometric testing with ambient temperatures 
less than 17 ° C or more than 40° C is not 
recommended. Ambient temperature should 
ALWAYS be recorded and reported to an ac-
curacy of ± 1 o C. Spirometer users should 
be aware of the problems with testing done 
at lower temperatures. Ranges of barometric 
pressures that are acceptable for the spirom-
eter should be published by the manufacturer. 
Rationale. There is evidence that some sub-
jects may develop airflow limitation with the 
inhalation of very cold air. Therefore, spirom-
etry should not be conducted when the am-
bient temperature is cold enough to induce 
airflow limitation. 
Recent studies also point out the problem 
of finite cooling times of gases in volume type 
spirometers and their associated tubing 
(52-54). In one of these studies, it was found 
that a + 7. 7 to 14% error of FEY 1 results 
if the volume type spirometer is at an am-
bient temperature of 3 o C, even with the BTPS 
correction. This error is less if the spirometer 
is warmer (nearer body temperature) (52) . As 
a result , 17 ° C was judged to be an accept-
able and reasonable lower limit. 
Complexities related to temperature are also 
encountered with flow-measuring devices 
(54-57) . Air exhaled from the mouth is esti -
mated to be at 33 ° C (55, 56). If any connect-
ing tubing is used between the mouthpiece 
and the flow sensor, the exhaled gas will ex-
perience a variable amount of cooling if the 
room temperature is not at 33 ° C. Details of 
the cooling pattern for flow spirometers have 
not been studied, but they may result in er-
rors similar to those for volume devices 
(54- 58). 
Because not all spirometers are used at sea 
level (BP = 760 mm Hg), the range of baro-
metric pressures allowed by the spirometer and 
it s associated computational equipment 
should be specified. 
Recommendation- FVC Use of 
Nose Clips 
Use of nose clips is encouraged. 
Rationale. Although the use of nose clips 
does not appreciably influence the FYC per-
formed using the open circuit technique, some 
subjects breathe through the nose during the 
maneuver when a closed circuit technique is 
used . 
Recommendation- FVC Sitting 
Versus Standing 
Subjects may be studied in the sitting or standing 
position. Indication of position is necessary. 
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Rationale. Recent studies by Townsend 
show that for adults there are significantly 
larger forced expiratory volumes in the stand-
ing position than in the sitting position (59). 
The earlier ATS recommendation indicates 
that in children, VC is greater in the standing 
than in the sitting position (I). 
VI. MEASUREMENT PROCEDURES 
Measurement 
Spirometric variables should be measured 
from a series of AT LEAST 3 acceptable 
forced expiratory curves. 
Rationale. Best efforts cannot always be 
determined by simple inspection of a spiro-
gram. Measurements and calculation are re-
quired to determine the largest values. 
Recommendation-Test Result 
Selection/Reporting of Results 
The largest FVC and the largest FEY, (BTPS) 
should be recorded, after examining the data 
from all of the acceptable curves, even if the 
2 values do not come from the same curve. 
Other measures such as the FEF,._,. ., 
and/or the instantaneous expiratory flows (V) 
should be obtained from the single "best test" 
curve (1 , 17). The "best test" curve is defined 
as the test that meets the acceptability criteria 
and gives the largest sum of FVC plus FEY, . 
Rationale. Two competing methods for se-
lection of FVC and FEV, values have been 
used: (I) using the largest FYC and the largest 
FEY, independent of which acceptable curve 
they came from, or (2) using the FYC and 
FEY, from the single "best test" curve with 
the largest sum of FYC plus FEY, . 
As a result of the original recommenda-
tions made by the ATS Snowbird Workshop, 
several investigators have evaluated the use 
of the "best test" method (60-62). The Univer-
sity of Arizona group used the single "best 
test" to reevaluate their data and found that 
construction of "composite" maximal expi-
ratory flow-volume (MEFY) curves gave re-
sults that were systematically higher than tak-
ing data from a "best test" waveform (60, 61). 
Sorensen and associates demonstrated that 
differences between maximal and "best test" 
FYC and FEY, were small. The mean differ-
ence between the 2-test result selection 
methods was only 5.8 ml for FYC and 8.4 ml 
for FEY,. In 98.407o of the FYC comparisons 
and 95.7% of the FEY, comparisons, the 
differences were within the minimal spirom-
eter accuracy recommendations ( ± 0.050 L 
or ± 3% of reading) (62) . 
The Committee decided to continue with 
the original Snowbird recommendation of 
taking the largest FYC and the largest FEY, 
independent of which curve they came from 
for the following reasons: (/)A large base of 
data, especially from epidemiologic studies, 
has been collected with the current recom-
mended methods, and because the differences 
between "largest" and "best test" were small, 
no change in the recommendation was justi-
fied. (2) The FVC and FEV, are independent 
and therefore may be selected from different 
curves. (3) The largest values represent a sub-
ject's highest potential values and therefore 
should be used for legal/regulatory purposes. 
In fact, these regulations are already in place 
and will not likely change. 
Because the average differences between the 
2 methods are so small (< 10 rnl), any refer-
ence value studies (63) or epidemiologic 
studies previously done with the "best test" 
method are still valid. 
VII. ACCEPTABILITY AND 
REPRODUCIBILITY 
Recommendation- FVC Maneuver 
Acceptability 
Acceptability will be determined by ascertain-
ing that the recommendations outlined above 
in the section on performing the FYC test are 
met. In review, these are: (I) end of test criteria, 
(2) minimum FVC exhalation time of 6 sec-
onds, and (3) satisfactory start of test. In ad-
dition, the technician should observe that the 
subject understood the instructions and per-
formed the maneuver with a maximum in-
spiration, with a good start, with a smooth 
continuous exhalation, with maximal effort, 
and without : 
(1) An unsatisfactory start of expiration, 
characterized by excessive hesitation or false 
start or extrapolated volume of greater than 
5% of FYC or 0.100 L, whichever is greater. 
(2) Coughing during the first second of the 
maneuver, thereby affecting the measured 
FEV, value, or any other cough that, in the 
technician's judgment, interferes with meas-
urement of accurate results. 
(3) Valsalva maneuver (glottis closure). 
(4) Early termination of expiration. (In a 
NORMAL subject this would be before com-
pletion of the breath- USUALLY less than 
a 6-s maneuver. In an obstructed subject , a 
longer time is required ([64, 65)). 
(5) A leak . 
(6) An obstructed mouthpiece, e.g., obstruc-
tion due to the tongue being placed in front 
of the mouthpiece, false teeth falling in front 
of the mouthpiece, etc. 
Figure 3 is a flow chart outlining how ac-
ceptability and reproducibility criteria are to 
be applied . 
Rationale. Many patients cough and sput-
ter toward the end of their FYC maneuver, 
but this does not affect the important initial 
spirometry parameters. To eliminate these 
FYC maneuvers from clinical evaluation 
would be a waste of useful information. AT 
LEAST3 acceptable maneuvers are required 
to ensure that maximal effort and coopera-
tion are obtained and that the resulting data 
provide an accurate reflection of the subject's 
pulmonary function (1). This conclusion was 
achieved after reviewing the data of Knud-
son and associates (66) and others (17, 67). 
Recent studies (48-50) have shown that the 
elimination of subjects for failure to meet the 
ATS reproducibility criteria may result in 
elimination of data from subjects who have 
abnormal lung function, resulting in a popu-
lation bias. Pennock and colleagues (68) have 
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reported that subjects with obstruction have 
greater coefficients of variation than do nor-
mal subjects. Therefore, these subjects are 
more likely to be unable to meet the ATS mini-
mum reproducibility criteria. The reproduci-
bility criteria have been clarified to eliminate 
confusion. If acceptability criteria are not ap-
plied before the reproducibility criteria, then 
a passive exhalation maneuver will often be 
labeled as the "best" maneuver because it may 
give the largest sum of FYC plus FEV ,. 
Recommendation- FVC Test 
Result Reproducibility 
As a goal during test result performance, the 
largest FVC and second largest FVC from ac-
ceptable curves should not vary by more than 
5% of reading (expressed as a percentage of 
the largest observed FVC regardless of the 
curve on which it occurred) or 0.100 L, 
whichever is greater. In addition to the FVC 
criteria, the largest FEV, and the second 
largest FEV, (expressed as a percentage of the 
largest observed FEV, regardless of the curve 
on which it occurred) should not vary by more 
than 5% of reading or 0.100 L, whichever is 
greater. 
The reproducibility criteria are used as a 
guide to whether more than 3 FVC maneu-
vers are needed; these criteria are NOT to be 
used for excluding results from reports or for 
excluding subjects from a study. Labeling 
results as being derived from data that do not 
conform to the reproducibility criteria stated 
above is encouraged (especially when the data 
suggests that bronchospasm was triggered by 
the FVC maneuver). The acceptability criteria 
should be applied before the reproducibility 
criteria (see figure 3). Unacceptable maneu-
vers should be discarded before applying the 
reproducibility criteria. 
The only criterion for unacceptable sub-
ject performance, requiring elimination from 
further consideration, is less than 2 accept-
able curves. No spirogram should be rejected 
solely on the basis of its poor reproducibil-
ity, provided 3 acceptable maneuvers were ob-
tained . Reproducibility of results should be 
considered at the time of interpretation. Use 
of data from maneuvers with poor reproduci-
bility is left to the discretion of the interpreter. 
Rationale. It was not clear from the earlier 
ATS statement on standardization of spirom-
etry, whether the 5% referred to FYC, FEY,, 
or both FVC and FEY,. Recent studies 
(48-50) have shown that the elimination of 
subjects for poor reproducibility may inap-
propriately eliminate subjects, resulting in a 
population bias. Pennock and associates have 
reported that subjects with airway obstruc-
tion have greater coefficients of variation than 
do normal subjects (68). Therefore, these sub-
jects are more likely to be unable to meet the 
initial ATS minimum reproducibility criteria. 
In addition, the reproducibility should be 
changed to eliminate any confusion concern-
ing which values are used and when the re-
producibility criteria are applied . If accept-
ability criteria are not applied before the 
reproducibility criteria, then a passive exha-
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lation maneuver may be labeled as the "best" 
maneuver if it gives the largest sum of FVC 
plus FEV1. 
The calculation of the FVC and FEV 1 
reproducibility presents no problem for a 
computer; however, the need for rapid deter-
mination of FEV 1 during the testing session 
presents a recognized logistics problem if 
results are hand-measured and calculated. 
VIII. REFERENCE VALUES AND 
INTERPRETATION STANDARDIZATION 
This area of spirometry standardization is.at 
an early stage in its development. The Inter-
mountain Thoracic Society has recently pub-
lished its Manual of Uniform Laboratory 
Procedures (17). The California Thoracic So-
ciety has published a similar book that em-
phasizes the controversy associated with 
selecting reference values and interpretation 
methodology (69). 
Reference value determination is clearly an 
area of spirometry that must be further in-
vestigated and standardized. There are well 
over 20 reference value equations for spirom-
etry in common use. Few data are available 
for several race and age groups. Although it 
is too early to standardize reference values, 
the committee recommends that, as a mini-
mum, reference values for FVC and FEV, 
come from the same study so that they are 
internally consistent. 
The standardization of interpretive proce-
dures is also in need of further investigation 
(70). The present situation allows enough in-
terpretive variability to cause identical data 
from a patient to be interpreted differently 
in different laboratories (71). 
IX. CLINICAL ASSESSMENT 
Clinical/Epidemiologic Considerations 
Whether the spirogram results are to be used 
for clinical or epidemiologic purposes, the 
above recommendations apply. 
Classification 
The classification of spirometry into normal 
and abnormal groupings and into disease cat-
egories such as mild, moderate, and severe 
airway obstruction is simple, and is easily per-
formed by a computer once criteria have been 
established. The meaning of such classifica-
tions requires clinical information. For exam-
ple, the meaning of an FVC measurement that 
is just below the lower limit of normal is differ-
ent in a young, healthy, nonsmoking indi-
vidual than it is in a person who presents for 
evaluation of dyspnea or who has an abnor-
mal chest radiograph. In the first case, the 
probability of a false positive test is large be-
cause the prior probability of disease is very 
low. In the second case, the probability of a 
true positive test is high because the symp-
toms and/or the abnormal radiograph in-
crease the prior probability of disease. One 
area that causes considerable controversy is 
the combined obstruction and restriction clas-
sification. This classification is commonly 
made when airway obstruction is present; the 
problem is the FVC is reduced out of propor-
tion to what was expected from the degree 
of obstruction. This problem may be more 
easily resolved when absolute lung volumes 
are available and approached in the context 
of the patient's clinical problems, and other 
· clinical information such as a chest radio-
graph is available. 
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APPENDIX A-Signal Processing Tutorial 
Since computers have come into such com-
mon use in spirometry and since fundamen -
tal errors have been detected in recently tested 
commercially available hardware and software 
(6), a short tutorial on signal processing is 
presented (figure 4). 
For volume spirometers, signals are gener-
ally derived from electrical voltages from a 
potentiometer. Some spirometers also use op-
tical shaft or position encoders (47). Flow 
devices of the Fleisch pneumotachometer va-
riety also have electrical voltage outputs. For 
the volume spirometer with a potentiometer, 
and the flow device with a flow transducer, 
the signal is sampled by a computer's analog 
to digital (A to D) converter. The ability of 
these systems to accurately measure the spiro-
gram depends on the volume or flow trans-
ducer's linearity, the accuracy and linearity 
of the electrical transducer (potentiometer). 
and the resolution of the A to D converter. 
A resolution of 12 bits (I part in 4,096-ra" 
resolution of from 0.002 to 0.004 L) for the 
A to D is recommended, although 10 bit s (l 
part in 1,024-raw resolution of from 0.008 
to 0.016 L) may be adequate. The sampling 
rate of the spirometer volume or flow is very 
important. Lemen and associates (72) ha,·e 
shown that for both infants and adults, 95 1ro 
of the signal energy in the flow-time of spiro -
grams is within a bandwidth of zero to 12 Hz. 
For the volume-time curve, 95 f1Jo of the signa I 
energy is contained from zero to 6Hz. Digi -
tal sampling theory requires that samples be 
taken at least twice the rate of the highest fre-
quency contained in the signal (73). Thus for 
volume-time spirograms, a 12-Hz sampling 
rate should be adequate. However, most 
volume-time spirograms are sampled at a 100 
Hz or greater rate to make measurements eas-
ier and more accurate. Figure 5 is a graphical 
illustration of time sampling of a volume-time 
spirogram. Computer system developer.' 
should be aware that even with 100-Hz sam-
pling, it may be necessary to linearly interpo-
late between sampling points to determine ac-
curate FEY, , FEF,.. ,..,, and other simila1 
spirometric measures. 

















Fig. 5. Time-sampled spirogram. 
and shaft or position encoders of the volume-
time signal have been used (47). This approach 
measures the time interval between uniform 
volume intervals (for example, 0.010 L) as 
shown in figure 6. In this case, the resolution 
of time interval between measurements dur-
ing rapid flow becomes a limiting factor. Ost-
ler and associates have recently addressed 
these issues (47). For example, if a resolution 
of flow to within ± 5 'J!o of reading at 12 Lis 
for a system with 0.010-L resolution is re-
quired, then a clock resolution of at least 40 
microsec is needed (47). 
APPENDIX B-Standard Waveforms for 
Spirometer Validation 
A recent study using the standard spirometry 
waveforms (6) described several ambiguities 





Fig. 6. Volume-sampled spirogram. 
6 . B. 1 • • 
values reported in terms of the revised ATS 
recommendations. The waveforms were ini-
tially obtained using an Ohio 840 spirometer 
(19). They were recorded on tape, then digi-
tized with a 12-bit analog to digital (A to D) 
converter. The published results were then 
reported to the nearest 10 ml or 10 mils. 
For clinical purposes, reporting of volumes 
to the nearest 10 ml is sufficient. At the time 
of the initial publication, it was felt that 10 
m! accuracy of the standard waveform values 
would be sufficient for any use. Many spirom-
eters at that time used only 10-bit A to D con-
verters, providing a volume resolution of 6 
ml for a 6-L spirometer. Because of the cur-
rent availability of spirometers with 12-bit A 
to D converters and, consequently, better reso-
lution, it became prudent to report all spirom-
etry parameters to the nearest ml, decreasing 
the small errors that may occur because of 
rounding. Therefore, the original waveforms 
AMERICAN THORACIC SOCIETY 
were reconverted from A to D units to volumes 
in ml and flows in ml/sec. In addition, all of 
the waveforms were extended to include no 
change in volume for 2.10 s following the last 
volume change (except 3, 4, and 17, which 
already stopped at 20.5 s). This satisfies the 
new spirometry end-of-test criteria for an "ob-
vious plateau." The revised values for FYC 
and the other parameters are shown in table 4 . 
The changes from the published values for 
forced vital capacity (FYC) were primarily due 
to differences caused by round-off. However, 
several of the original waveform data files 
started with non-zero volume offset. The 
small offsets were a result of patients chang-
ing the amount of air in the spirometer by 
moving the patient hose before their expira-
tion actually began. To avoid any ambigui-
ties, these waveforms (Nos. 6, 7, 8, 11, 12, 15, 
17, 21, 23) were modified by subtracting the 
small offset volume from all subsequent 
values in the data file. The largest difference 
was noted on Waveform 17, resulting in a de-
crease of 17 ml in the FYC. The other wave-
forms had offsets of either 1.5 or 3 mi. 
The values for the FEY, were updated using 
interpolation between data points. The previ-
ous method found the zero time by back ex-
trapolating from the highest flow, then count-
ing 100 samples (I s) . Differences resulted be-
cause the back extrapolated time zero did not 
usually fall exactly at one of the sample times. 
The revised parameters calculated the exact 
time zero intercept on the time axis by linear 
interpolation, then calculated the FEY, by in-
terpolating between points. The back extrapo-
lated volume was also modified slightly be· 
cause of the interpolation scheme used. 
The FEFmax was unchanged since it was 
calculated as before, using a parabolic curve 
fitting routine to smooth the flow data. The 
parabolic curve fitting algorithm smoothed 
the data using a least squares parabolic fit 
to 80 millisec of the volume time curve. The 
formula used for the smoothing (74) was: 
TABLE 3 
SAMPLE POINTS VERSUS INTERPOLATED 
VALUES FOR 25% FVC AND 75% FVC 





0 .28 1.442 24 .3 
0 .2839' 1.4843 25.0 
0 .29 1.549 26.1 
0.77 4.449 74 .9 
0.7711' 4.4528 75.0 
0.78 4.479 75.4 
FEF,_, .,. USING CALCULATED VERSUS 
INTERPOLATED POINTS 
-------- - ·---- ---
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TABLE 4 4 
VALUES FOR STANDARD WAVEFORMS L. j•y (n + jh) 
y' (n) = -4 
FVC FEV, Vext FEFmax FEF,._,.., 4 
Curve (L) (L) %FVC (L) DfoFVC (Us) (Us) 2* L. j*j*h 
1 6.000 4.262 71 .0 0.052 0.9 6.497 3.410 
j 
2 4.999 4.574 91 .5 0.068 1.4 9.873 5.683 where h = the time between samples. 
3 3.498 1.188 32.0 0.014 0.4 1.380 0.644 Calculating the FEF,._,.~, from the digi-4 1.498 1.371 91 .5 0.019 1.3 2.952 1.704 
5 5.132 3.868 75.4 0.087 1.7 7.535 3.209 tized waveform data revealed a problem simi-
6 4.011 3.027 75.5 0.317 7.9 5.063 2.572 lar to that described for the FEV ,. When data 
7 3.169 2.519 79.5 0.354 11.2 4.750 2.368 points for 2507o of the FVC and 75% of the 
8 1.993 1.615 81 .0 0.151 7.6 3.450 1.857 FVC were not included in the file, these points 
9 4.854 3.772 77.7 0.203 4.2 7.778 3.365 had to be interpolated from the data points 
10 3.843 3.031 78.9 0.244 6.3 4.650 2.899 available. Errors as large as 5% were intro-
11 2.735 1.811 66 .2 0.022 0.8 3.708 1.272 duced into the calculation of FEF,._,~, 
12 2.002 1.621 81 .0 0.094 4.7 3.807 1.780 when interpolation was not used (6). Table 
13 4.896 3.834 78 .3 0.460 9.4 5.207 3.677 3 illustrates the effect on Waveform 15. 
14 3.786 3.053 80.6 0.338 10.2 4.368 3.122 The forced expiratory time (FET) was de-15 5.937 5.304 89.3 0.080 1.3 12.132 6.092 
16 5.458 3.896 71 .4 0.215 3.9 7.395 2.892 fined as the time from time zero until the time 
17 5.833 2.597 44.5 0.035 0.6 5.257 1.153 of the last change in volume. 
18 4.343 3.155 72.6 0.042 1.0 7.523 2.335 
19 3.935 2.512 63.8 0.044 1.1 5.408 1.137 APPENDIX C- Standard Waveforms 
20 2.881 2.563 89.0 0.041 1.4 5.822 2.695 Values for the standard waveforms are in-
21 4.477 3.549 79.3 0.102 2.3 9.398 3.368 
eluded as table 4. Plots of the volume-time 22 3.857 2.813 72.9 0.036 0.9 5.055 2.204 
23 3.419 1.360 39.8 0.013 0.4 2.868 0.531 and flow-volume curves for the 24 standard 
24 1.237 0.922 74.5 0.037 3.0 2.095 0.709 waveforms are also included. 














Vo 1 ume Ill 
~c - 6.000 
FEV, • 4.262 
FEFmax • 6.497 
FEFu-r._. • 3.410 
t. 
Vox! • 0.052 0.9% 











'I a 1 ume Ill 
j;~c - 5.132 
FEV, • 3.888 
FEFmax • 7.535 
FEF,.. , ..._, • 3.209 
Vox! • 0.087 
Time zero defect 

















Vo 1 ume Ill 
W~c - 4.999 
FEV, • 4.574 
FEFmax • 9.873 
FEFn· r~11141 5.683 Vox! • 0 .068 1 4% 
Exponential TC - 0.4 sec 
Normal/Good effort 




FEFn -nCM. • 2.572 
Ve•t • 0.317 7.9% 
Time zero defect 
End of test 













~ ,. W~c ~ 3.498 
FEV, • 1.188 
FEFmax , 1 .380 
' ~ 
FEFn_,,_. • 0.664 
Vox! • 0.014 0.4% 
Exponential TC .,. 2.4 sec 
.. ·-







Vo 1 ume Ill 






FEF,. ,.~ • 2.368 
Vext 
- 0.354 11 .2% 
Time zero defect 
Large extrapolated volume 













Vo 1 ume Ill 
~c • 1.498 
FEV, • 1.371 
FEFmax • 2.952 
c;~u-r.._ - 6:~~ 1.3% 
Exponential TC - 0.4 sec 
Small vital capacity 
vo 1 ume (LJ 
(8) 
FVC 1.993 
FEV, • 1.815 
FEFmax - 3.450 
FEF21.,~ • 1.857 
Vex! • 0.151 

















F'VC - 4.854 
FEV, • 3.m 
FEFmax • 7.n8 
FEF".'"- • 3.365 
lloxt • 0.203 4.2% 
Time zero defect 
Va 1 ume ILl 
• 4 .896 
FEV, • 3.834 
FEFmax • 5.207 
FEFu 71~ • 3.0T7 
Vext • 0.460 
















. -·., .. - · 
Vo 1 ume ILl 
W% • 3.843 
FEV, • 3.031 
FEFmax • 4.650 
FEFu -n-., • 2.899 
Voxl • 0 244 
Time zero detect 
Va 1 ume Ill 
w~ . 3.786 
FEV, • 3.053 
FEFmax • 4.368 
FEFu-n..._ • 3122 
Voxl • 0.338 






















Va l ume ILl 
• 2 .735 
FEV, • 1.811 
FEFmax • 3. 708 
FEFn ,. .. • 1.272 
Voxl • 0.022 
Time zero defect 
Volume Ill 
w~ . 5.937 
FEV, • 5.304 
0.8% 
FEFmax • 12 .132 
FEFn ·u"" • 6.092 
Voxl • 0.080 

























Va l ume ILl 
(12) 
F'VC - 2 .002 
FEV, • 1.621 
FEFmax • 3.807 
FEF11_7.,_ • 1.780 
1/oxt • 0.094 
Time zero defect 
Volu me (L) 
• 5.458 
FEV, • 3.896 
FEFmax • 7.395 
FEF,. . , 1~ • 2.892 
Voxl • 0.215 
End ot test 





























Vo 1 ume (L) 
~ - 5.833 
FEV, 2.5!17 
FEFmax • 5.257 
FEF15. ,.._ • 1.153 
VeK1 - 0.035 0.6% 




Vo 1 ume (L) 
(21) 
1"\A:: • Hn 
FEV, • 3.549 
FEFmax • 9.398 
FEF,.. ,...., • 3.368 
Vexl • 0.102 






















Vo 1 ume (L) 
~~ 4.343 
FEV, 3.155 
FEFmaK • 7523 
FEF U · """ .. 2.335 
VeKt • 0.042 1.0% 





Vo lume (L) 
- 3.857 
FEV, • 2.813 
FEFmaK • 5.055 
FEFu . 15"" • 2.204 
Vex! • 0.036 






























Vo 1 ume (L) 
~~ 3.935 
FEV, 2.512 
FEFmaK • 5.408 
FEFu-n-.., .., 1.137 
VeKt • 0.044 1.1% 
End of test 
Airway obstruction 



































Vo 1ume (L) 
(20) 
~ - 2.881 
FEV, 2.563 
FEFmax • 5l!22 
FEF,.. ,.'t. • 2 .695 
\leKt • 0.041 1.4% 
End of test 
Variable ftow at end 
Vo 1 ume (L) 
- 1.237 
FEV, • 0.922 
FEFmax • 2 .095 
FEF15. , ,IMI • 0.709 
VeKt • 0.037 3.0% 
Variable trow at end 
• 
' 
-- -- -----------------------~ 
